Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ... Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006 | 655 | 2006 |
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development MA Zocco, E Di Stasio, R De Cristofaro, M Novi, ME Ainora, F Ponziani, ... Journal of hepatology 51 (4), 682-689, 2009 | 577 | 2009 |
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment FR Ponziani, MA Zocco, C Campanale, E Rinninella, A Tortora, ... World journal of gastroenterology: WJG 16 (2), 143, 2010 | 436 | 2010 |
The role of small intestinal bacterial overgrowth in Parkinson's disease A Fasano, F Bove, M Gabrielli, M Petracca, MA Zocco, E Ragazzoni, ... Movement Disorders 28 (9), 1241-1249, 2013 | 354 | 2013 |
Post-COVID-19 global health strategies: the need for an interdisciplinary approach Aging clinical and experimental research 32 (8), 1613-1620, 2020 | 323 | 2020 |
Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial EC Nista, M Candelli, F Cremonini, IA Cazzato, MA Zocco, F Franceschi, ... Alimentary pharmacology & therapeutics 20 (10), 1181-1188, 2004 | 261 | 2004 |
Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection G Cammarota, R Cianci, O Cannizzaro, L Cuoco, G Pirozzi, A Gasbarrini, ... Alimentary pharmacology & therapeutics 14 (10), 1339-1343, 2000 | 241 | 2000 |
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 213 | 2018 |
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation FR Ponziani, MA Zocco, F D’Aversa, M Pompili, A Gasbarrini World journal of gastroenterology 23 (25), 4491, 2017 | 194 | 2017 |
High prevalence of celiac disease in patients with lactose intolerance V Ojetti, G Nucera, A Migneco, M Gabrielli, C Lauritano, S Danese, ... Digestion 71 (2), 106-110, 2005 | 166 | 2005 |
Breath testing for human liver function assessment A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, ... Alimentary pharmacology & therapeutics 16 (12), 1977-1996, 2002 | 158 | 2002 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication EC Nista, M Candelli, MA Zocco, F Cremonini, V Ojetti, R Finizio, C Spada, ... Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006 | 152 | 2006 |
Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial EC Nista, M Candelli, F Cremonini, IA Cazzato, S Di Caro, M Gabrielli, ... Alimentary pharmacology & therapeutics 18 (6), 627-633, 2003 | 145 | 2003 |
Levofloxacin based regimens for the eradication of Helicobacter pylori S Di Caro, MA Zocco, F Cremonini, M Candelli, EC Nista, F Bartolozzi, ... European journal of gastroenterology & hepatology 14 (12), 1309-1312, 2002 | 128 | 2002 |
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction MA Zocco, ME Ainora, G Gasbarrini, A Gasbarrini Digestive and Liver Disease 39 (8), 707-712, 2007 | 127 | 2007 |
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications FR Ponziani, MA Zocco, L Cerrito, A Gasbarrini, M Pompili Expert review of gastroenterology & hepatology 12 (7), 641-656, 2018 | 125 | 2018 |
Moxifloxacin‐based strategies for first‐line treatment of Helicobacter pylori infection EC Nista, M Candelli, MA Zocco, IA Cazzato, F Cremonini, V Ojetti, ... Alimentary pharmacology & therapeutics 21 (10), 1241-1247, 2005 | 103 | 2005 |
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure C Di Campli, MA Zocco, N Saulnier, A Grieco, G Rapaccini, G Addolorato, ... Digestive and Liver Disease 39 (12), 1071-1076, 2007 | 97 | 2007 |
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications FR Ponziani, V Gerardi, S Pecere, F D’Aversa, L Lopetuso, MA Zocco, ... World journal of Gastroenterology 21 (43), 12322, 2015 | 93 | 2015 |
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis A Gasbarrini, GL Rapaccini, S Rutella, MA Zocco, P Tittoto, G Leone, ... Digestive and Liver Disease 39 (9), 878-882, 2007 | 92 | 2007 |